WEDGE CAPITAL MANAGEMENT L L P/NC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1015308
CHARLOTTE, NC
Position in REGN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$30,683,079
-$1,196,695 QoQ
Shares Held
39,712
-3.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 71.43180902497986.ToString("F0")%
Shared 0.ToString("F0")%
None 28.568190975020148.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $111,356,380 across 7 Biotechnology names. REGN ranks #2 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
890,840 | $42,733,594 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
39,712 | $30,683,079 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,006 | $30,249,134 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
88,999 | $2,492,861 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
24,535 | $2,133,808 | |
| 6 | SVRA |
Savara Inc
|
307,998 | $1,681,669 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
19,704 | $1,382,235 |
All Filings in REGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,683,079 | 39,712 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $31,879,774 | 41,302 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $25,411,792 | 45,195 | Shares | Sole | 2025-10-10 | |
| No filing history on record for this holder in this stock. | ||||||